Log In
BCIQ
Print this Print this
 

NovoTTF-100L(O)

  Manage Alerts
Collapse Summary General Information
Company Novocure Ltd.
DescriptionNon-invasive portable device that disrupts the division of cancer cells in the ovaries using low-intensity, alternating electric fields at 200 kHz
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Electromagnetic
Latest Stage of DevelopmentPhase II
Standard IndicationOvarian cancer
Indication DetailsTreat recurrent ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today